Poland: Panaxia and Neuraxpharm expand collaboration into Poland

Panaxia Labs Israel, a publicly traded global pharma company specialising in medical cannabis products and its partner, Neuraxpharm, a European pharma company focused on the treatment of Central Nervous System (CNS) disorders, have expanded their strategic collaboration into the Polish market. The companies will manufacture, commercialise, and distribute Panaxia’s medical cannabis-based products in Poland. The agreement follows previous…

You must be a HMI Subscriber to view this content.

Subscribe Now »